HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Hepama-1 mAb

(131)I-labeled anti-hepatocellular carcinoma (HCC) monoclonal antibody for treatment of patients with HCC

Also Known As:

(131)I-Hepama-1 mAb; DGDK-1 mAb; Hepama-1 mAb monoclonal antibody

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Hepama-1 mAb: 1
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Hepama-1 mAb: 1
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Hepama-1 mAb: 1

Related Diseases

1.	Hepatocellular Carcinoma (Hepatoma) 11/01/1994 - "Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial 131I-labeled Hepama-1 mAb. Preliminary results and discussion."